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Abstract 
Cerebral ischemia leads to neurological damage and cognitive defects. Restoring blood flow to the 
brain is the most effective way to limit damage of cerebral tissue; however, reperfusion is also 
associated with tissue injury in the form of oxidative stress. Oxidative stress is characterized by the 
generation of free radicals resulting in damage to lipids, proteins and nucleic acids, which in turn 
contribute to cell death.  The antioxidant glutathione is constitutively present in the body and is 
responsible for neutralizing free radicals produced by oxidative stress. The primary hypothesis of 
this experiment was that the administration of N-acetyl-L-cysteine (NAC), a glutathione precursor, 
would act as a buffer against stroke damage. Transient focal cerebral ischemia was induced by 
middle cerebral artery occlusion (MCAO). All experimental animals were treated with either NAC 
(150mg/kg) or isotonic saline solution. Our behavioral data indicate that MCAO decreases 
exploratory behavior and induces sensorimotor deficits including reduced mobility and precision of 
limb control during walking. The treatment of MCAO mice with NAC, however, improved control 
and strength in the affected hind limb. Additionally, following stroke, NAC-treated mice showed 
improved mobility in the affected hind limb.  Additionally, NAC treatment produced a trend of 
reduced oxidative stress as well as reduced infarct volume relative to saline treatment, which likely 
contributed to improved sensorimotor recovery.  Taken together, these preliminary data suggest a 
role for anti-oxidant therapy in improving post-stroke functional recovery. 
Introduction 
Stroke is the third leading cause of death in the United States and in most industrialized 
countries after cardiovascular disease and cancer1, 8. A stroke is characterized by a rapid onset of 
neurological impairment due to a block of blood flow to the brain, frequently caused by an arterial 
thrombus or an embolus lodged from a distant site.1 When cerebral blood flow falls below a critical 
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threshold, as it does in ischemic stroke, then the microvascular delivery of vital nutrients to neurons, 
thus neuronal functioning, is compromised.4 Currently, tissue plasminogen activator, a thrombolytic 
agent with a narrow 3-hour therapeutic window, is the only US Food and Drug Administration-
approved therapy available for treatment of stroke patients.6  Lack of other available treatment 
options has promoted studies to examine the underlying mechanisms of cerebral ischemic injury in 
order to reveal potential treatments. Studies in humans have discovered that social isolation can have 
a negative impact on stroke outcome, whereas social support can have neuroprotective effects from 
the consequences of stroke3. Furthermore, affiliative social interaction improves cerebral ischemia 
outcome.5 Additional evidence has demonstrated that oxytocin (OT), a neuropeptide released during 
social interaction, confers neuroprotection by decreasing inflammation and increasing antioxidant 
activity. In particular, the increased antioxidant activity is believed to reduce stroke damage by 
combating a condition called oxidative stress. Cerebral ischemia causes a sustained oxidative stress 
that significantly increases during reperfusion8. Oxidative stress following stroke is characterized by 
the generation of free radicals, specifically reactive oxygen species (ROS) 1, resulting in damage to 
lipids, proteins and nucleic acids thus contributing to the progression of cell death10.  The central 
nervous system is particularly vulnerable to the effects of oxidative damage due to the metabolically 
expensive character of neurons, the large amount of lipids in the brain being a target for lipid 
peroxidation and the lack of sufficient antioxidant defenses against ROS8. 
Following stroke, the generation of ROS such as superoxide anion (O2-), hydrogen peroxide 
(H2O2) and peroxinitrite (ONOO-) result in lipid peroxidation, excitotoxicity and inflammation11. 
Antioxidants counter the toxic effects of these free radicals by catalyzing their decomposition into 
less harmful molecules. For example, the enzyme glutathione peroxidase (GPx) catalyzes the 
reaction between the antioxidant, glutathione, and the ROS, H2O2, to water and the oxidized form 
of glutathione. Following this reaction, the oxidized form of glutathione is recycled back to its 
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reduced form by the enzyme glutathione reductase. The reduced form of the antioxidant is necessary 
in order to continue the decomposition of ROS into less harmful molecules.  
The neurodegeneration caused by stroke can lead to many forms of impairment including 
gait impairment. Gait not only is an indicator of lower extremity motor function, but also indicates 
cognitive function, particularly executive function.12 Furthermore, retraining of walking is a major 
goal in the rehabilitation program for persons after stroke.9 Analyzing gait and ambulation in 
laboratory animals following MCAO may indicate the extent of the damage caused by oxidative 
stress. N-acetylcysteine (NAC) has been reported to effectively scavenge ROS and to increase the 
rate of endogenous glutathione synthesis. Because the antioxidant glutathione eliminates the ROS 
responsible for causing neuronal damage, its precursor NAC may be a promising therapeutic agent 
for the treatment of the stroke and its subsequent impairments8. 
The goals of the present study were to determine the effects of post-ischemic antioxidant 
administration on stroke outcome. The primary purpose of this study was to determine whether 
treatment with the glutathione precursor, NAC, reduces the oxidative stress, improves mobility, and 
decreases infarct size following middle cerebral artery occlusion (MCAO). The primary hypothesis 
was that administration of the antioxidant NAC following the ischemic event improves stroke 
outcome by decreasing oxidative stress, size of the infarct and gait impairment.  
Materials and Methods 
Animals 
 Adult male C57/BL6 mice (Charles River, Wilmington, Massachusetts) weighing 23g to 30g, 
were maintained on a 14:10 light/dark cycle in a temperature and humidity-controlled vivarium. All 
animals were allowed ad libitum access to food (Harlan Teklad 8640, Indianapolis, IN) and filtered 
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tap water throughout the study.  All experimental animals were housed individually beginning one 
week prior to surgery and throughout the reperfusion period. The study was conducted in 
accordance with National Institutes of Health guidelines for the care and use of animals and under 
protocols approved by The Ohio State University Institutional Animal Care and Use Committee.  
Experimental Protocols 
Study 1: The Effects of NAC on Oxidative Stress, Glutathione Concentration, Exploratory 
Behavior and Gait following MCAO 
 To assess the effects of NAC on oxidative stress, glutathione concentration and mobility 
following MCAO, 20 animals were assigned randomly to one of four main experimental groups: 
sham surgery with saline administration (Sham-Sal, n=5), sham surgery with NAC administration 
(Sham-NAC, n=5), MCAO surgery with saline administration (MCAO-Sal, n=5) and MCAO 
surgery with NAC administration (MCAO-NAC, n=5). Baseline measures of exploratory behavior 
and gait were taken one day prior to surgery and reassessed two days post-surgery. Approximately 30 
minutes after the exploratory behavior was assessed, animals were euthanized and tissue was 
collected for the lipid peroxidation and glutathione peroxidase assays. Serum samples were also 
collected for the determination of circulating glutathione peroxidase. 
Study 2: The Effects of NAC on Infarct Size and Gait following MCAO 
 To assess the effects of NAC on stroke volume and gait following MCAO, 19 mice were 
randomly assigned to one of two experimental groups: 1) MCAO surgery with saline administration 
(MCAO-Sal, n=9); 2) MCAO surgery with NAC administration (MCAO-NAC, n=10). Baseline 
measures of gait were taken one day prior to surgery and reassessed two days post-surgery. On post-
operative day two, approximately 30 minutes after gait was assessed, animals were euthanized and 
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tissue was collected. Sectioned tissue was then stained using TTC in order to perform the stroke 
volume analysis. 
Drug Administration 
 All animals were treated with two intraperitoneal injections of NAC (150mg/kg) or the 
saline vehicle. Drug administration occurred immediately prior to MCAO and again 24 hours 
following MCAO.  
Surgery 
 The MCAO and sham surgeries were performed on anesthetized mice (isofluorane), using 
sterile surgical technique. Transient focal cerebral ischemia was induced under anesthesia by middle 
cerebral artery occlusion (MCAO).  Briefly, unilateral MCAO was achieved by insertion of a 6-0 
nylon monofilament into the internal carotid artery to a point 6mm beyond the internal carotid-
pterygopalatine artery bifurcation. Once secured, the wound was sutured and the animal was allowed 
to awaken from anesthesia. After 60 minutes of occlusion, the animal was re-anesthetized and 
reperfusion was initiated by removal of the filament. For SHAM surgeries, the internal carotid artery 
was exposed but not disrupted.  
Behavioral Testing 
 Each animal underwent baseline behavioral testing 24 hours prior to MCAO and again 48 
hours after reperfusion. Behavioral testing was conducted during the light phase. The apparatuses 
were thoroughly cleaned between animals using a 70% alcohol solution.   
Open Field 
 Exploratory behavior was assessed in an open field apparatus using Flex Field photobeam 
activity (San Diego Instruments, San Diego, CA).  The apparatus was enclosed in a sound 
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attenuating chamber equipped with a ventilating fan which provides masking noise.  A clear 
Plexiglas insert (40 X 40 X 37.5 cm) was fitted inside a metal frame consisting of 16 equally spaced 
infrared photocell detectors.  Interruptions in the infrared light sources by the experimental animal 
were recorded in the associated computer program.  Animals were individually placed inside the 
apparatus for 60-minute sessions and data were analyzed to determine general locomotor activity 
and relative amount of activity occurring in the periphery versus the center of the apparatus. 
Gait Analysis 
 Assessment of gait dynamics and posture was assessed using DigiGait Imaging System 
(Mouse Specifics Inc., Quincy, MA). Animals were placed on a transparent treadmill and required to 
run while a camera below recorded the locomotor activity. 3-5 second segments of locomotor 
activity were used to analyze gait characteristics. 
Glutathione Peroxidase Assay 
 Forebrain tissue was removed, homogenized in 20mM tris-buffered saline, and then 
centrifuged to remove insoluble components. Glutathione peroxidase activity was detected in the 
tissue homogenate with a specific assay kit (Cayman Chemical, Ann Arbor, MI). The kit measures 
glutathione peroxidase activity indirectly by a coupled reaction with recycled glutathione reductase. 
When glutathione peroxidase reduces hydroperoxide and produces oxidized glutathione, the 
glutathione reductase and NADPH can then recycle the glutathione to its reduced state. When 
NADPH is oxidized to NADP+, the absorbance is reduced to 350nm. The assay was conducted in a 
96-well plate and read on a microplate reader. Sample glutathione peroxidase activity was derived 
from a standard curve. 
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Lipid Peroxidation 
 Lipids were extracted from forebrain homogenates with chloroform. Lipid peroxidation was 
assessed using a kit (Calbiochem). The kit detects lipid hydroperoxides directly. Hydroperoxides 
catalyze the conversion of ferrous ions into ferric ions. The resulting ferric ions are then detected 
with a thiocyanate-based chromagen. All samples for a single experiment were run in one assay and 
compared to a standard curve. 
Infarct Size Analysis 
 Immediately following cervical dislocation and decapitation, fresh brains were removed, 
flash frozen and sectioned into five 2-mm-thick coronal section.  They were then incubated for 12-
minutes with 2,3,5-triphenyltetrazolium (TTC) at 37˚C. Slices were post-fixed with 10% buffered 
formalin for three to six days before image analysis, at which point the slices were photographed and 
infarct area throughout the cerebrum will be analyzed using Inquiry software (Loats Associates, Inc., 
Rockville, MD). Infarct size was determined as a percentage of the contra-lateral hemisphere after 
correcting for edema. 
Statistical Analysis 
 The data are expressed as mean ± standard error of the mean. Testing of statistical 
significance was performed, using analysis of variance (ANOVA) or t-tests. When a significant 
overall treatment effect was reported, post hoc analyses were conducted, using the Tukey test. 
Group differences were considered statistically significant at p<0.05. 
Results 
Study 1. NAC Reduces Oxidative Stress Gait Deficits to Sham Levels 
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 Among saline-treated animals, following MCAO, oxidative stress was significantly increased 
when compared with sham animals (SHAM vs. MCAO+SAL: t18 = 2.74, p < 0.02). However, NAC-
treated mice that sustained MCAO displayed reduced levels of oxidative stress similar to those of 
sham mice. The assay for oxidative stress measures a ratio of ferrous ions to ferric ions. The higher 
the ratio, the lower the oxidative stress. Contrary to expectations, there were no significant 
differences in the brain or serum glutathione peroxidase enzyme concentrations among any of the 
groups. NAC treatment did not influence glutathione peroxidase concentration. 
 
 
 
 
 
  
  
 MCAO decreases exploratory behavior. Both sham groups exhibited similar levels of general 
locomotor activity and anxiety-like behavior in an open-field apparatus. Following MCAO, both 
saline and NAC-treated animals displayed a significant decrease in exploratory behavior (PRE vs. 
POST: Center - t38 = 5.95, p < 0.01; Total - PRE vs. POST: t38 = 4.853, p < 0.01).  
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 Gait analysis indicates that following MCAO, 
saline-treated mice show a significant increase in 
duration of swing in their affected hind leg when 
compared to sham animals (SHAM vs. MCAO+SAL: 
t10 = 2.47, p < 0.05).  Although NAC-treated animals 
did not show a significant decrease in mean duration 
of swing compared to the saline-treated animals 
following MCAO, there was no difference between 
the NAC-treated animals and the sham animals. A 
similar pattern was apparent for the mean duration of 
propulsion. Following MCAO, saline-treated mice 
show a significant increase in mean duration of 
propulsion in their affected hind leg when compared 
to sham animals (SHAM vs. MCAO+SAL: t10 = 3.26, p 
< 0.01). Although NAC-treated animals did not show 
a significant decrease in mean duration of propulsion 
compared to the saline-treated animals following 
MCAO, there was no difference between the NAC-treated animals and the sham animals. Both 
saline-treated and NAC-treated animals showed a significant decrease in mean duration of braking 
following MCAO SHAM vs. MCAO = t15 = 4.99, p < 0.01). 
_*_ 
_*_ 
__*__ 
Study 2: NAC Treatment Significantly Reduces Volume of Post-Ischemic Lesion
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of infarct when compared with saline-treated animals (MCAO Saline vs. MCAO NAC =  t11 = 3.41, 
p < 0.01).  
Discussion 
 The increased production of ROS following cerebral ischemia and particularly during 
reperfusion is implicated in overwhelming the endogenous antioxidant systems leading to increased 
tissue damage. Evaluation of endogenous antioxidant systems or oxidized molecules in the brain 
tissue shows oxidative stress after ischemia. This oxidative stress is defined by decreased 
concentration of reduced glutathione.8 The current study suggests that antioxidant treatment, 
specifically NAC, may increase the concentration of reduced glutathione, thus decreasing oxidative 
stress following MCAO. Although saline-treated mice show a significant increase in oxidative stress 
following MCAO, NAC-treated mice reduced oxidative stress so that there was no significant 
difference between NAC-treated mice and sham mice. Also, NAC treatment did not influence 
oxidative stress in the absence of the MCAO. Levels of glutathione peroxidase were not elevated in 
the brain or the serum of the animals following NAC treatment. This could be attributed to an 
already sufficient level of the enzyme in the body in order to catalyze the oxidizing reaction.  
 As expected, the MCAO procedure precipitated decreases in exploratory behavior assessed 
by open-field analysis. Following MCAO, both saline and NAC-treated groups decreased beam 
brakes in the center of the field, and overall this indicates a decrease in exploratory behavior. NAC 
treatment did not influence exploratory behavior. Furthermore, sham groups decreased exploratory 
behavior; however, this is likely attributed to a habituation response. Both saline and NAC-treated 
groups following MCAO experienced a much greater reduction in exploratory behavior than sham 
operated mice, indicating stroke-induced locomotor deficits. 
12 
 
 Data trends suggest that NAC treatment following MCAO may improve gait. Mean swing 
duration is significantly increased in saline-treated mice following MCAO when compared to sham 
animals; however, mean swing duration is not significantly increased in NAC-treated mice following 
MCAO. Increased swing duration indicates decreased mobility. Mean propulsion duration is 
significantly increased in saline-treated mice following MCAO when compared to sham animals; 
however, mean propulsion duration is not significantly increased in NAC-treated mice following 
MCAO. An increase in propulsion duration suggests a decrease in strength and control in the 
affected limb. Mean brake duration was significantly decreased in both saline and NAC-treated 
animals when compared to sham animals. A decrease in brake duration indicates a decrease in 
precision of control and distribution of loading during stance. Taken together, these data provide 
the first evidence that treatment with NAC following stroke may improve mobility, thus indicating a 
neuroprotective effect from NAC.   
 The data from Study 2 replicated previous findings that NAC significantly influences the 
volume of the post-ischemic lesion. The volume of the post-ischemic lesion determined using a 
mitochondrial stain. The presence of mitochondria indicates the presence of living cells, whereas the 
absence of mitochondria indicates the presence of dead cells. Therefore, treatment with NAC 
prevents neuronal death. The concomitant decrease in oxidative stress and size of infarct, paired 
with the decrease in gait impairment in NAC-treated animals following MCAO supports the 
hypothesis that NAC treatment may work as a neuroprotective buffer against the damage caused by 
stroke. Reducing gait impairment in humans following stroke is particularly important because 
impaired gait function not only reduces ambulation, but could also lead to imbalance and falls. This 
is especially of concern in elderly patients experiencing stroke.12 Numerous studies have recognized 
antioxidants as potential treatments for stroke.1,8,11 No neuroprotective approaches, however, have 
been approved in the United States or Europe despite the success of a variety of compounds in 
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animal models of stroke.8  Apart from the data in the present study, the antioxidant properties of 
NAC have been well described. Thus, in conjunction with previous reports on the effects of NAC 
and similar antioxidants on oxidative stress and infarct size, these data shed light onto the 
neuroprotective effects of NAC. The most important difference, however, between previous studies 
and the present work concerns the effects of NAC on gait impairment. 
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